 LTM 3Q18 Revenue $10.1 billion, +24% YoY, Core EBITDA margin 13.7%  Core EBITDA of $409m in 3Q18, +40% YoY; $1,379m LTM 3Q18 (45% YoY)  LTM 3Q18 Core EPS THB 4.49, +65% post 11.1% dilution from

Ventures 2nd Quarter 2018 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 2nd Quarter 2018 Structural Improvements Driving Earnings Momentum  2Q18 Core EBITDA up 63% YoY, 1H18

from marketing of the new clients at the end of , KT Medical Services Co., Ltd. provides health care facilities for patients with end-stage chronic kidney disease who receive replacement therapy with

growth and returns while maintaining our market leadership over the long term. Guided by our core strategies of “Customer Centricity” and making KBank the Customers’ Main Bank for all eight customer

เป็นพิเศษ? สัดส่วนของประเภททรัพย์สินที่ลงทุน ผลกำรด ำเนินงำน ค่ำธรรมเนียม ข้อมูลอื่นๆ กำรลงทุนในกองทุนรวมไม่ใชก่ำรฝำกเงิน กองทุนเปิด เอ โกลบอลเฮลธแ์คร์ : A Global Health Care (ACARE) กองทุนรวมหมวดอุตสำ

 of New Subsidiary (Revised No.2) on 3 April 2017    The Board of Directors Meeting of Ekachai Medical Care Public Company Limited (the “Company”) No. 1/2018  held on 26th February 2018 has passed a

 / CS / 2560/016 Establishment of New Subsidiary (Revised No.2) on 3 April 2017    The Board of Directors Meeting of Ekachai Medical Care Public Company Limited (the “Company”) No. 1/2018  held on 26th

other persons’ accounts in such a way as to take advantage of other persons by using non- public material information concerning the fact that SUPER would sell off its assets of all kinds in its core

(0) 2661-6664 2 INDORAMA VENTURES PUBLIC CO., LTD (SET: “IVL”) MANAGEMENT DISCUSSION AND ANALYSIS (MD&A) FOR THE PERIOD OF 2Q 2017 (CONSOLIDATED) Table 1: Financial Summary - Core Financials of

proportion in core business from the minimum of 75% of the total number of voting rights to that of 50%, strengthening investor protection by revising rules on holding company?s investment structure to ensure